Timothy S. Heuer

1.8k total citations · 1 hit paper
19 papers, 1.4k citations indexed

About

Timothy S. Heuer is a scholar working on Molecular Biology, Cancer Research and Infectious Diseases. According to data from OpenAlex, Timothy S. Heuer has authored 19 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 11 papers in Cancer Research and 3 papers in Infectious Diseases. Recurrent topics in Timothy S. Heuer's work include Cancer, Lipids, and Metabolism (11 papers), Cancer, Hypoxia, and Metabolism (10 papers) and Peroxisome Proliferator-Activated Receptors (6 papers). Timothy S. Heuer is often cited by papers focused on Cancer, Lipids, and Metabolism (11 papers), Cancer, Hypoxia, and Metabolism (10 papers) and Peroxisome Proliferator-Activated Receptors (6 papers). Timothy S. Heuer collaborates with scholars based in United States, France and Germany. Timothy S. Heuer's co-authors include Patrick O. Brown, George Kemble, Douglas Buckley, Julie Lai, Jules A. Hoffmann, Kasia Mordec, Marina Fridlib, Jean‐Marc Reichhart, Marcia Belvin and Richard Ventura and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Biochemistry and Cancer Research.

In The Last Decade

Timothy S. Heuer

19 papers receiving 1.4k citations

Hit Papers

A genome-wide analysis of immune responses in Drosophila 2001 2026 2009 2017 2001 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Timothy S. Heuer United States 11 805 544 290 255 238 19 1.4k
Erica Pascal United States 8 1.0k 1.2× 168 0.3× 202 0.7× 40 0.2× 86 0.4× 10 1.5k
Susanna M. Rybak United States 27 1.1k 1.4× 133 0.2× 559 1.9× 61 0.2× 116 0.5× 54 1.8k
Mary Ann Accavitti-Loper United States 13 794 1.0× 114 0.2× 652 2.2× 323 1.3× 24 0.1× 18 1.6k
Gilles A. Spoden Germany 21 639 0.8× 244 0.4× 304 1.0× 57 0.2× 74 0.3× 23 1.4k
Nahum Sonenberg Canada 19 2.6k 3.2× 118 0.2× 239 0.8× 188 0.7× 96 0.4× 24 3.0k
Yu-Chih Lo Taiwan 17 1.1k 1.3× 430 0.8× 539 1.9× 106 0.4× 14 0.1× 34 1.6k
Jürgen Neumann Germany 11 556 0.7× 112 0.2× 369 1.3× 50 0.2× 90 0.4× 16 1.2k
Helen Yu United States 19 1.3k 1.6× 142 0.3× 183 0.6× 268 1.1× 217 0.9× 26 2.0k
Mark Manzano United States 15 561 0.7× 266 0.5× 90 0.3× 133 0.5× 44 0.2× 21 1.0k
Sheng‐Hao Chao Singapore 19 925 1.1× 72 0.1× 188 0.6× 99 0.4× 135 0.6× 42 1.3k

Countries citing papers authored by Timothy S. Heuer

Since Specialization
Citations

This map shows the geographic impact of Timothy S. Heuer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Timothy S. Heuer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Timothy S. Heuer more than expected).

Fields of papers citing papers by Timothy S. Heuer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Timothy S. Heuer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Timothy S. Heuer. The network helps show where Timothy S. Heuer may publish in the future.

Co-authorship network of co-authors of Timothy S. Heuer

This figure shows the co-authorship network connecting the top 25 collaborators of Timothy S. Heuer. A scholar is included among the top collaborators of Timothy S. Heuer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Timothy S. Heuer. Timothy S. Heuer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Zaytseva, Yekaterina Y., Piotr Rychahou, Timothy Scott, et al.. (2018). Preclinical evaluation of novel fatty acid synthase inhibitors in primary colorectal cancer cells and a patient-derived xenograft model of colorectal cancer. Oncotarget. 9(37). 24787–24800. 97 indexed citations
2.
Buckley, Douglas, Gregory Duke, Timothy S. Heuer, et al.. (2017). Fatty acid synthase – Modern tumor cell biology insights into a classical oncology target. Pharmacology & Therapeutics. 177. 23–31. 151 indexed citations
4.
Zaytseva, Yekaterina Y., Piotr Rychahou, Tianyan Gao, et al.. (2016). Abstract 1010: Evaluation of small-molecule FASN inhibitors in preclinical models of colorectal cancer. Cancer Research. 76(14_Supplement). 1010–1010. 2 indexed citations
6.
Heuer, Timothy S., Richard Ventura, Julie Lai, et al.. (2016). Abstract 4743: Preclinical studies characterize tumor type sensitivity to FASN inhibition and the mechanism and efficacy of novel drug combinations with TVB-2640. Cancer Research. 76(14_Supplement). 4743–4743. 1 indexed citations
7.
O’Farrell, Marie, R. Webster Crowley, Timothy S. Heuer, et al.. (2015). Abstract 2675: Biomarker and PK/PD analyses of first in class FASN inhibitor TVB-2640 in a first-in-human phase 1 study in solid tumor patients. Cancer Research. 75(15_Supplement). 2675–2675. 2 indexed citations
9.
O’Farrell, Marie, R. Webster Crowley, Timothy S. Heuer, et al.. (2015). Abstract B13: Biomarker Analyses from Dose Escalation Phase of FASN Inhibitor TVB-2640 Phase 1 Study Shows Target Engagement in Solid Tumor Patients. Molecular Cancer Therapeutics. 14(12_Supplement_2). B13–B13. 1 indexed citations
10.
Benjamin, Daniel I., et al.. (2015). Diacylglycerol Metabolism and Signaling Is a Driving Force Underlying FASN Inhibitor Sensitivity in Cancer Cells. ACS Chemical Biology. 10(7). 1616–1623. 51 indexed citations
11.
Heuer, Timothy S., Richard Ventura, Kasia Mordec, et al.. (2015). Abstract 4446: Discovery of tumor types highly susceptible to FASN inhibition and biomarker candidates for clinical analysis. Cancer Research. 75(15_Supplement). 4446–4446. 2 indexed citations
12.
Trowe, Torsten, Sotiria Boukouvala, Richard E. Cutler, et al.. (2008). EXEL-7647 Inhibits Mutant Forms of ErbB2 Associated with Lapatinib Resistance and Neoplastic Transformation. Clinical Cancer Research. 14(8). 2465–2475. 94 indexed citations
15.
Troxler, Laurent, Timothy S. Heuer, Marcia Belvin, et al.. (2001). A genome-wide analysis of immune responses in Drosophila. Proceedings of the National Academy of Sciences. 98(26). 15119–15124. 328 indexed citations breakdown →
16.
Heuer, Timothy S. & Patrick O. Brown. (1998). Photo-Cross-Linking Studies Suggest a Model for the Architecture of an Active Human Immunodeficiency Virus Type 1 Integrase−DNA Complex. Biochemistry. 37(19). 6667–6678. 133 indexed citations
17.
Heuer, Timothy S. & Patrick O. Brown. (1997). Mapping Features of HIV-1 Integrase Near Selected Sites on Viral and Target DNA Molecules in an Active Enzyme−DNA Complex by Photo-Cross-Linking. Biochemistry. 36(35). 10655–10665. 116 indexed citations
18.
Dotan, Iris, Brian Scottoline, Timothy S. Heuer, & Patrick O. Brown. (1995). Characterization of recombinant murine leukemia virus integrase. Journal of Virology. 69(1). 456–468. 33 indexed citations
19.
Heuer, Timothy S., P. Scott Chandry, Marlene Belfort, Daniel W. Celander, & Thomas R. Cech. (1991). Folding of group I introns from bacteriophage T4 involves internalization of the catalytic core.. Proceedings of the National Academy of Sciences. 88(24). 11105–11109. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026